A randomized crossover observational study in a teaching hospital with nine myeloma patients ( one male , two with known type 2 diabetes ( KDM ) , mean age 69.0 6.7 years ) were investigated using a standard 75 g Oral Glucose Tolerance Test ( patients without KDM ) and a 3-day continuous glucose monitoring ( CGM -- all patients ) during and between dexamethasone cycles .